Lion Chemtech라이온켐텍

Lion Chemtech shows a profitable half-year 2026 on higher margins, but the share price has fallen over the past year and the company faces a loan extension decision.

Lion Chemtech makes artificial marble for building interiors and exteriors and synthetic wax for industrial use. On a trailing twelve-month basis to H1 2026 it reports revenue of ₩145.5B... corrected to ₩145.5B is wrong; revenue is ₩145B, operating income ₩17.7B and net income ₩16.7B, well above its 2025 annual figures. The share price closed at ₩2,020 on 2026-10-16, down 6.3% over one year, and the company trades at a low multiple of book value.

What stands out

• Trailing revenue is about ₩145B with an operating margin of 12.2%, up from 8.7% for full-year 2025 and 6.6% in 2024.
• 2025 revenue fell 8.1% year on year, while the trailing figures to H1 2026 show a larger top line than any year in the annual data provided.
• Valuation metrics are low: P/E of 4.3, P/B of 0.5 and a dividend yield of 5%, with a DCF base fair value of ₩3,127 in the provided model.
• Liabilities are 16.8% of equity and cash of ₩47.2B exceeds borrowings of ₩11B, according to the filed figures.
• Filings in 2026 include a Decision on Loan Extension (Aug), a half-year report, a corporate value-up plan and a cash dividend decision in January.

What to watch

• The loan extension decision filed on 2026-08-26 and what terms it sets for the ₩11B of borrowings.
• Full-year 2026 results and whether the margin improvement from H1 2026 holds.
• Foreign ownership is only 3.3% and retail investors were net sellers over the last 20 days, so trading interest may stay thin; the data does not give a reason for the price fall.